Content area
Details
Title
ASO Visual Abstract: Factors Affecting Recurrence and Survival in High-Risk Stage II Melanoma
Author
Dedeilia, Aikaterini 1 ; Lwin, Thinzar 2 ; Li, Siming 3 ; Tarantino, Giuseppe 4 ; Tunsiricharoengul, Sasha 5 ; Lawless, Aleigha 6 ; Sharova, Tatyana 3 ; Liu, David 4 ; Boland, Genevieve M. 1 ; Cohen, Sonia 1
1 Massachusetts General Hospital, Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924); Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623)
2 City of Hope National Medical Center, Division of Surgical Oncology, Duarte, USA (GRID:grid.410425.6) (ISNI:0000 0004 0421 8357)
3 Massachusetts General Hospital, Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924)
4 Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623); Dana-Farber Cancer Institute, Department of Medical Oncology, Center for Immuno-Oncology, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910)
5 Harvard University, Boston, USA (GRID:grid.38142.3c) (ISNI:0000 0004 1936 754X)
6 Massachusetts General Hospital, Cancer Center, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924)
1 Massachusetts General Hospital, Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924); Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623)
2 City of Hope National Medical Center, Division of Surgical Oncology, Duarte, USA (GRID:grid.410425.6) (ISNI:0000 0004 0421 8357)
3 Massachusetts General Hospital, Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924)
4 Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623); Dana-Farber Cancer Institute, Department of Medical Oncology, Center for Immuno-Oncology, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910)
5 Harvard University, Boston, USA (GRID:grid.38142.3c) (ISNI:0000 0004 1936 754X)
6 Massachusetts General Hospital, Cancer Center, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924)
Pages
2749-2750
Publication year
2024
Publication date
Apr 2024
ISSN
10689265
e-ISSN
15344681
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2933848203
Copyright
© Society of Surgical Oncology 2024.